Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
- Status
- COMPLETED
- Phase
- PHASE2
Protocol Calcineurin Inhibitor (CNI) Weaning
- Status
- TERMINATED
- Phase
- PHASE3
A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease
- Status
- TERMINATED
- Phase
- PHASE2
Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf
- Status
- COMPLETED
- Phase
- NA
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients
- Status
- COMPLETED
- Phase
- PHASE2
Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
- Status
- COMPLETED
- Phase
- PHASE1
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Drug Interaction of ASP015K and Tacrolimus
- Status
- COMPLETED
- Phase
- PHASE1
Tandem Auto-Allo Transplant for Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression-
- Status
- TERMINATED
- Phase
- PHASE3
Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1